OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1556-1561

  Bou, Germán ^a,b   Oliver, Antonio ^b   Martínez Beltrán, Jesús ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CEFALORIDINE; CLAVULANIC ACID; PENICILLIN G; SULBACTAM; TAZOBACTAM;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ACINETOBACTER; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CLONING, MOLECULAR; METALLOPROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SUBSTRATE SPECIFICITY;

EID: 0034077976     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1556-1561.2000     Document Type: Article

References (38)

1. Afzal, M. S., and D. Livermore. 1998. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 41:576-577.
2. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. Lord. Biol. Sci. 289:321-331.
3. Amyes, S. G. B., and H.-K. Young. 1996. Mechanism of antibiotic resistance in Acinetobacter spp. - genetics of resistance, p. 185-223. In E. Bergogne-Berezin, M. L. Joly-Guillou, and K. J. Towner (ed.), Acinetobacter: microbiology, epidemiology, infections, management, 1996. CRC Press, New York, N.Y.
4. Bergogne-Bérézin, E. 1996. Resistance of Acinetobacter spp. to antimicrobials - overview of clinical resistance patterns and therapeutic problems, p. 133-183. In E. Bergogne-Berezin, M. L. Joly-Guillou, and K. J. Towner (ed.), Acinetobacter: microbiology, epidemiology, infections, management, 1996. CRC Press, New York, N.Y.
5. Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
6. Bou, G., and J. Martínez-Beltrán. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
7. Brown, S., C. Bantar, H. K. Young, and S. G. B. Amyes. 1998. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. Lancet 351:186-187.
8. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
9. Clark, R. B. 1996. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 KDa outer membrane protein. J. Antimicrob. Chemother. 38:245-251.
10. Danel, F., L. M. C. Hall, D. Gur, and D. M. Livermore. 1995. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1881-1884.
11. Danel, F., L. M. C. Hall, D. Gur, and D. M. Livermore. 1997. OXA-15, an extended-spectrum variant of OXA-2 β-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrob. Agents Chemother. 41:785-790.
12. Danel, F., L. M. C. Hall, D. Gur, and D. M. Livermore. 1988. OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrob. Agents Chemother. 42:3117-3122.
13. Danel, F., L. M. C. Hall, B. Duke, D. Gur, and D. M. Livermore. 1999. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: 1362-1366.
14. Da Silva, G. J., R. Leitão, and L. Peixe. 1999. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J. Clin. Microbiol. 37:2109-2110.
15. Donald, H. M., W. Scaife, S. G. B. Amyes, and H.-K. Young. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.
16. Gehrlein, M., H. Leying, W. Cullmann, S. Wendt, and W. Opferkuch. 1991. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy 37:405-412.
17. Hall, L. M. C., D. M. Livermore, D. Gur, M. Akova, and H. E. Akalin. 1993. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:1637-1644.
18. Hornstein, M., C. Sautjeau-Rostoker, J. Peduzzi, A. Vessieres, L. T. Hong, M. Barthelemy, M. Seavizzi, and R. Labia. 1997. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii. FEMS Microbiol. Lett. 153:333-339.
19. Joly-Guillou, M. L., E. Bergogne-Bérézin, and A. Philippen. 1988. Distribution of β-lactamases and phenotypic analysis in clinical strains of Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 22:597-604.
20. Jones, M. E., C. Thornsberry, D. M. Livermore, and D. F. Sahma. 1999. Prevalence of Acinetobacter spp. with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network. J. Antimicrob. Chemother. 43:429-431.
21. Levi, I., and E. Rubinstein. 1996. Acinetobacter infections - overview of clinical features, p. 101-115. In E. Bergogne-Berezin, M. L. Joly-Guillou, and K. J. Towner (ed.), Acinetobacter: microbiology, epidemiology, infections, management, 1996. CRC Press, New York, N.Y.
22. Martínez-Beltrán, J., M. Alvarez, and M. P. Sierra. 1998. Acinetobacter baumannii en pacientes criticos, p. 21-43. Merck Sharp & Dohme de España S.A., Madrid, Spain.
23. Masuda, G., S. Tomioka, and M. Hasegawa. 1976. Detection of β-lactamase production by Gram-negative bacteria. J. Antibiot. (Tokyo) 29:662-664.
24. Matthew, M., A. M. Harris, M. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
25. Mugnier, P., I. Casin, A. T. Bouthors, and E. Collatz. 1998. Novel OXA-10-derived extended-spectrum β-lactamases selected in vivo or in vitro. Antimicrob, Agents Chemother. 42:3113-3116.
26. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4, National Committee for Clinical Laboratory Standards, Wayne, Pa.
27. Paton, R., R. S. Miles, J. Hood, and S G. B. Amyes. 1993. ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
28. Perilli, M., A. Felici, A. Oratore, G. Cornaglia, G. Bonfiglio, G. M. Rossolini, and G. Amicosante. 1996. Characterization of the chromosomal cephalosporinases produced by Acinetobacter Iwoffii and Acinetobacter baumannii clinical isolates. Antimicrob. Agents Chemother. 40:715-719.
29. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
30. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
31. Sanschagrin, F., F. Couture, and R. C. Levesque. 1995. Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D β-lactamases. Antimicrob. Agents Chemother. 39:887-893.
32. Sato, K., and T. Nakae. 1991. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28:33-45.
33. Spratt, B. G., P. J. Hedge, T. S. Heesen, A. Edelman, and J. K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8, and pEMBL9. Gene 41:337-342.
34. Vahaboglu, H., R. Öztürk, G. Aygün, F. Coşkunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
35. Vecoli, C., F. E. Prevost, J. J. Ververis, A. A. Medeiros, and G. P. O'Leary, Jr. 1983. Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of -lactamases. Antimicrob. Agents Chemother. 24:186-189.
36. Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Vergara, R. Reig, R. Gomez-Lus, and T. Jiménez De Anta. 1993. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyl-transferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
37. Vila, J., M. Navia, J. Ruiz, and C. Casals. 1997. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 41:2757-2759.
38. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.